Corey Davis | LifeSci Advisors |
Glenn Mattes | President & Chief Executive Officer |
Dr. Dale Christensen | Director of Clinical Development |
Dr. Bill Williams | University of Texas, Austin |
Kirk Coleman | Chief Financial Officer |
Chris Cano | Chief Operating Officer |
Jonathan Aschoff | ROTH Capital Partners |
Sahil Kazmi | B. Riley Securities |
Michael Okunewitch | Maxim Group |
Richard Deutsch | National Securities |
Greetings, ladies and gentlemen, and thank you for standing by. Welcome to the TFF Pharmaceuticals Third Quarter 2021 Results Conference Call.
As a reminder, this conference call is being recorded. A question-and-answer session will follow the formal presentation. [Operator Instructions].